nimodipine
PolandDrugs containing this active substance
-
The medicine is used to prevent neurological disorders caused by cerebral vasospasm resulting from subarachnoid hemorrhage (a type of brain hemorrhage caused by a ruptured aneurysm).
Form: solution for infusion
Active substance Dosage nimodipine 10 mg ATC: C08CA06
Manufacturer: Laboratorio Reig Jofré S.A.
-
The medicine is used to prevent neurological disorders resulting from cerebral vasospasm following subarachnoid hemorrhage (a type of brain hemorrhage caused by a ruptured aneurysm).
Form: solution for infusion
Active substance Dosage nimodipine 0.2 mg/ml ATC: C08CA06
Manufacturer: Altan Pharmaceuticals, S.A.
-
The drug is used to prevent and treat neurological damage caused by cerebral vasospasm occurring after subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: solution for infusion
Active substance Dosage nimodipine 0.2 mg/ml ATC: C08CA06
Manufacturer: Bayer AG
-
The medicine is used to prevent and treat neurological damage caused by cerebral vasospasm occurring after subarachnoid hemorrhage resulting from a ruptured aneurysm.
Form: solution for infusion
Active substance Dosage nimodipine 0.2 mg/ml ATC: C08CA06
Manufacturer: Laboratoire X.O
-
The drug is used for the prevention and treatment of ischemic neurological deficits caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Laboratoire X.O
-
The drug is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the prevention and treatment of ischemic neurological deficits resulting from cerebral vasospasm following subarachnoid hemorrhage caused by an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer AG
-
The drug is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the treatment and prevention of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer S.A.
-
The medicine is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the oral continuation of treatment and prevention of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer AG
-
The medicine is used to prevent and treat ischemic neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer S.A.
-
The medicine is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the oral continuation of treatment and the prevention of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer AG
-
The drug is used to prevent cerebral ischemia by dilating blood vessels. It is intended for the prevention and treatment of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
Manufacturer: Bayer Portugal, Ltd.